Last update :
27/11/2024
Anticancer drug   Eribulin mesylate  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Elefix Argentina
Halaven Argentina, Belgium, Brazil, Canada, Chile, Denmark, Finland, France, Germany, Great Britain, Hungary, Iceland, Ireland, Italy, Japan, Luxembourg, Malaysia, Mexico, Norway, Peru, Romania, Slovenia, Spain, Sweden, Switzerland
Stability in solutions   injection   Stability in solutions : Eribulin mesylate     
Container Solvent Concentration Temperature Storage Duration of stability References
Polyolefine Sodium chloride 0,9% 0,015 >> 0,043 mg/ml 18-22°C With or without light
14 Day
3331
Level of evidence A

Polyolefine Sodium chloride 0,9% 0,015 >> 0,043 mg/ml 2-6°C Protect from light
14 Day
3331
Level of evidence A

Polyolefine Sodium chloride 0,9% 0.02 mg/ml 2-8°C Protect from light
28 Day
3707
Level of evidence A

Polyolefine Sodium chloride 0,9% 0.02 mg/ml 25°C Protect from light
28 Day
3707
Level of evidence A

Polypropylen Syringe Sodium chloride 0,9% 0.205 mg/ml 2-8°C Protect from light
28 Day
3707
Level of evidence A

Polypropylen Syringe Sodium chloride 0,9% 0.205 mg/ml 25°C Protect from light
28 Day
3707
Level of evidence A

Polypropylen Syringe None 0,44 mg/ml 18-22°C With or without light
14 Day
3331
Level of evidence A

Polypropylen Syringe None 0,44 mg/ml 2-6°C Protect from light
14 Day
3331
Level of evidence A

Not specified Sodium chloride 0,9% 0,018 >> 0,18 mg/ml 2-8°C Not specified
24 Hour
3250
Manufacturer's stability data


  Mentions Légales